ArticleJournal of experimental & clinical cancer research : CR2019

Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer.

Aikaterini Emmanouilidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.